Skip to main content
. 2018 Mar 12;18:276. doi: 10.1186/s12885-018-4187-y

Table 2.

Frequency of lymphoma subtypes in outpatient and inpatient cohorts

Subtypea Total (N = 1719) QDU (1) OPs (n = 688) QDU (2) OPs (n = 496) Total OPs 1 (n = 1184) IPs 2 (n = 535) P value 1 vs 2
Classical Hodgkin lymphoma 318 (18.5) 128 (18.6) 88 (17.7) 216 (18.2) 102 (19.1) .164
 Nodular sclerosis, NOSb 235 (73.9) 96 (75.0) 66 (75.0) 162 (75.0) 73 (71.6) .045
 Mixed cellularity, NOSc 37 (11.6) 16 (12.5) 10 (11.4) 26 (12.0) 11 (10.8) .135
 Lymphocyte richd 13 (4.1) 5 (3.9) 3 (3.4) 8 (3.7) 5 (4.9) .140
 Lymphocyte depletion, NOSe 4 (1.3) 1 (0.8) 0 (0.0) 1 (0.5) 3 (2.9) .078
 Classical Hodgkin lymphoma, NOSf 29 (9.1) 10 (7.8) 9 (10.2) 19 (8.8) 10 (9.8) .156
Large B-cell lymphomag 578 (33.6) 218 (31.7) 151 (30.4) 369 (31.2) 209 (39.1) <.001
Follicular lymphoma, NOSh 562 (32.7) 250 (36.3) 189 (38.1) 439 (37.1) 123 (23.0) <.001
Mature nodal peripheral T-cell lymphomai 261 (15.2) 92 (13.4) 68 (13.7) 160 (13.5) 101 (18.9) <.001
 Peripheral T-cell lymphoma, NOSj 147 (56.3) 50 (54.3) 37 (54.4) 87 (54.4) 60 (59.4) <.001
 Angioimmunoblastic T-cell lymphomak 77 (29.5) 28 (30.4) 21 (30.9) 49 (30.6) 28 (27.7) .076
 Anaplastic large cell lymphoma, ALK-negativel 37 (14.2) 14 (15.2) 10 (14.7) 24 (15.0) 13 (12.9) .086

Abbreviations: NOS not otherwise specified; ALK anaplastic lymphoma kinase. For other abbreviations, see Table 1

aThe ICD-O-3 codes of the International Classification of Diseases for Oncology, 3rd edition [32], are shown for each lymphoma subtype; b9663/3; c9652/3; d9651/3; e9653/3; f9650/3; g9680/3, 9684/3, 9735/3, 9688/3, and 9679/3 (anaplastic large B-cell lymphoma, diffuse large B-cell lymphoma associated with chronic inflammation, primary diffuse large B-cell lymphoma of the CNS, primary cutaneous DLBCL leg type, and EBV positive diffuse large B-cell lymphoma of the elderly were excluded); h9690/3; i9702/3; j9702/3; k9705/3; l9702/3